Rasubala L, Pernapati L, Velasquez X, Burk J, Ren Y
PLoS One. 2015; 10(8):e0135957.
PMID: 26274819
PMC: 4537135.
DOI: 10.1371/journal.pone.0135957.
Islam M, McRae I
BMC Pharmacol Toxicol. 2014; 15:46.
PMID: 25127880
PMC: 4138942.
DOI: 10.1186/2050-6511-15-46.
Sowa E, Fellers J, Raisinghani R, Santa Cruz M, Hidalgo P, Lee M
Prim Care Companion CNS Disord. 2014; 16(1).
PMID: 24940523
PMC: 4048139.
DOI: 10.4088/PCC.13m01566.
Nosyk B, Fischer B, Sun H, Marsh D, Kerr T, Rehm J
Am J Addict. 2014; 23(3):257-64.
PMID: 24724883
PMC: 4033518.
DOI: 10.1111/j.1521-0391.2014.12091.x.
Furlan A, MacDougall P, Pellerin D, Shaw K, Spitzig D, Wilson G
Pain Res Manag. 2014; 19(2):102-6.
PMID: 24716198
PMC: 4028653.
DOI: 10.1155/2014/634171.
Measures such as interstate cooperation would improve the efficacy of programs to track controlled drug prescriptions.
Deyo R, Irvine J, Millet L, Beran T, OKane N, Wright D
Health Aff (Millwood). 2013; 32(3):603-13.
PMID: 23406570
PMC: 3835343.
DOI: 10.1377/hlthaff.2012.0945.
Reductions in non-medical prescription opioid use among adults in Ontario, Canada: are recent policy interventions working?.
Fischer B, Ialomiteanu A, Kurdyak P, Mann R, Rehm J
Subst Abuse Treat Prev Policy. 2013; 8:7.
PMID: 23406368
PMC: 3599879.
DOI: 10.1186/1747-597X-8-7.
Consumer/patient encounters with prescription drug monitoring programs: evidence from a Medicaid population.
Goodin A, Blumenschein K, Freeman P, Talbert J
Pain Physician. 2012; 15(3 Suppl):ES169-75.
PMID: 22786455
PMC: 3545447.
Time series analysis of California's prescription monitoring program: impact on prescribing and multiple provider episodes.
Gilson A, Fishman S, Wilsey B, Casamalhuapa C, Baxi H
J Pain. 2011; 13(2):103-11.
PMID: 22112420
PMC: 4063415.
DOI: 10.1016/j.jpain.2011.09.006.
Deaths related to the use of prescription opioids.
Fischer B, Rehm J
CMAJ. 2009; 181(12):881-2.
PMID: 19969577
PMC: 2789122.
DOI: 10.1503/cmaj.091791.
